361:
338:
29:
1531:
552:
Shafiq N, Malhotra S, Pandhi P, Sharma N, Bhalla A, Grover A (2006). "A randomized controlled clinical trial to evaluate the efficacy, safety, cost-effectiveness and effect on PAI-1 levels of the three low-molecular-weight heparins--enoxaparin, nadroparin and dalteparin. The ESCAPe-END study".
133:
88:
385:
1604:
51:
451:
For the treatment and prevention of DVT, the drug is administered as a subcutaneous injection (under the skin), usually around the abdomen. It is on the
1580:
1373:
611:
703:
1487:
452:
858:
654:
1468:
876:
849:
589:
204:
118:
803:
1573:
604:
1087:
414:
277:
1504:
1178:
898:
317:
1260:
1234:
1226:
500:
472:
1566:
597:
1492:
69:
356:
841:
765:
76:
1369:
445:
1431:
1010:
965:
433:
425:
173:
333:
1538:
821:
221:
578:
429:
28:
1274:
677:
672:
532:
1599:
1356:
1127:
1117:
1107:
1102:
1097:
1072:
645:
632:
624:
570:
145:
61:
41:
1330:
1161:
1122:
1092:
562:
508:
155:
1530:
286:
1134:
441:
424:
Nadroparin is used in general and orthopedic surgery to prevent thromboembolic disorders (
230:
163:
360:
337:
1550:
1546:
1498:
1025:
711:
620:
1593:
1455:
1425:
1015:
1000:
995:
956:
628:
349:
80:
582:
1445:
1415:
1393:
1388:
1361:
1310:
1289:
1139:
1078:
1034:
911:
854:
793:
788:
769:
667:
636:
437:
101:
96:
20:
1315:
1243:
1212:
1144:
1045:
1039:
1029:
932:
726:
716:
1420:
1337:
1320:
1305:
1284:
1269:
1264:
1207:
1192:
1166:
1156:
1151:
1005:
974:
906:
886:
864:
753:
737:
733:
682:
373:
261:
505:
World Health
Organization model list of essential medicines: 22nd list (2021)
1408:
1403:
1383:
1378:
1325:
1279:
1253:
1248:
1197:
1055:
978:
942:
916:
881:
869:
831:
826:
816:
778:
748:
743:
721:
687:
662:
186:
55:
574:
1202:
1187:
1020:
991:
982:
970:
937:
783:
413:, among others) is an anticoagulant belonging to a class of drugs called
241:
513:
250:
1473:
1463:
1440:
1238:
1067:
811:
566:
1435:
418:
306:
1542:
697:
1342:
297:
593:
212:(4S,6R)-6-oxy-3,4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate
322:
127:
140:
1554:
453:
392:
1454:
1355:
1298:
1225:
1177:
1066:
1054:
964:
955:
925:
897:
840:
802:
764:
696:
653:
644:
372:
367:
348:
316:
296:
276:
260:
240:
220:
195:
185:
172:
162:
154:
117:
112:
87:
68:
50:
40:
35:
229:
1574:
605:
436:. It is also used to prevent clotting during
8:
19:
1581:
1567:
1063:
961:
650:
612:
598:
590:
359:
336:
27:
512:
285:
1605:Blood and blood forming organ drug stubs
473:"Fraxiparine PRODUCT MONOGRAPH (Canada)"
464:
332:
249:
209:
350:
18:
507:. Geneva: World Health Organization.
417:(LMWHs). Nadroparin was developed by
60:
7:
1527:
1525:
100:
305:
14:
1529:
1227:Direct thrombin (IIa) inhibitors
655:Glycoprotein IIb/IIIa inhibitors
850:Thromboxane synthase inhibitors
46:Fraxiparin(e), Fraxodi, others
1:
415:low molecular weight heparins
1553:. You can help Knowledge by
1088:Low-molecular-weight heparin
899:Phosphodiesterase inhibitors
812:Acetylsalicylic acid/Aspirin
191:clearance 21.4mL/min (+/- 7)
1621:
1524:
517:. WHO/MHP/HPS/EML/2021.02.
368:Chemical and physical data
1482:
1060:(with some II inhibition)
537:National Cancer Institute
501:World Health Organization
382:
200:
26:
1541:article relating to the
432:), and as treatment for
62:International Drug Names
440:, and for treatment of
1370:Plasminogen activators
842:Thromboxane inhibitors
766:Prostaglandin analogue
77:Subcutaneous injection
1432:serine endopeptidases
966:Vitamin K antagonists
533:"NCI Drug Dictionary"
446:myocardial infarction
1547:blood forming organs
1179:Direct Xa inhibitors
1011:Ethyl biscoumacetate
877:Receptor antagonists
434:deep vein thrombosis
426:deep vein thrombosis
822:Carbasalate calcium
181:3.7 hours (SC dose)
136:(Prescription only)
23:
1509:Never to phase III
1357:Thrombolytic drugs
1073:glycosaminoglycans
646:Antiplatelet drugs
633:antiplatelet drugs
430:pulmonary embolism
21:Nadroparin calcium
1562:
1561:
1519:
1518:
1351:
1350:
1221:
1220:
951:
950:
567:10.1159/000096484
539:. 2 February 2011
419:Sanofi-Synthélabo
400:
399:
318:CompTox Dashboard
143:
131:
16:Chemical compound
1612:
1583:
1576:
1569:
1533:
1526:
1331:Drotrecogin alfa
1311:Antithrombin III
1162:Dermatan sulfate
1135:Oligosaccharides
1064:
962:
698:ADP receptor/P2Y
651:
614:
607:
600:
591:
586:
548:
546:
544:
519:
518:
516:
497:
491:
490:
488:
486:
477:
469:
396:
395:
388:
363:
352:
341:
340:
326:
324:
309:
289:
253:
233:
177:
142:
139:
129:
126:
104:
64:
31:
24:
22:
1620:
1619:
1615:
1614:
1613:
1611:
1610:
1609:
1590:
1589:
1588:
1587:
1522:
1520:
1515:
1514:
1499:Clinical trials
1478:
1450:
1360:
1347:
1294:
1217:
1173:
1076:
1071:
1059:
1050:
1026:1,3-Indandiones
968:
947:
921:
893:
836:
798:
760:
712:Thienopyridines
701:
692:
640:
621:Antithrombotics
618:
551:
542:
540:
531:
528:
523:
522:
499:
498:
494:
484:
482:
480:Aspripharma.com
475:
471:
470:
466:
461:
444:and non-Q wave
442:unstable angina
391:
389:
386:(what is this?)
383:
378:4300 g/mol
344:
320:
312:
292:
272:
256:
236:
216:
213:
208:
207:
175:
164:Bioavailability
156:Pharmacokinetic
150:
108:
71:
17:
12:
11:
5:
1618:
1616:
1608:
1607:
1602:
1592:
1591:
1586:
1585:
1578:
1571:
1563:
1560:
1559:
1534:
1517:
1516:
1513:
1512:
1511:
1510:
1507:
1496:
1490:
1484:
1483:
1480:
1479:
1477:
1476:
1471:
1466:
1460:
1458:
1452:
1451:
1449:
1448:
1443:
1438:
1428:
1423:
1418:
1413:
1412:
1411:
1406:
1398:
1397:
1396:
1391:
1386:
1381:
1366:
1364:
1353:
1352:
1349:
1348:
1346:
1345:
1340:
1335:
1334:
1333:
1323:
1318:
1313:
1308:
1302:
1300:
1296:
1295:
1293:
1292:
1287:
1282:
1277:
1272:
1267:
1258:
1257:
1256:
1251:
1246:
1231:
1229:
1223:
1222:
1219:
1218:
1216:
1215:
1210:
1205:
1200:
1195:
1190:
1184:
1182:
1175:
1174:
1172:
1171:
1170:
1169:
1164:
1159:
1149:
1148:
1147:
1142:
1132:
1131:
1130:
1125:
1120:
1115:
1110:
1105:
1100:
1095:
1084:
1082:
1061:
1052:
1051:
1049:
1048:
1042:
1037:
1032:
1023:
1018:
1013:
1008:
1003:
998:
988:
986:
959:
957:Anticoagulants
953:
952:
949:
948:
946:
945:
940:
935:
929:
927:
923:
922:
920:
919:
914:
909:
903:
901:
895:
894:
892:
891:
890:
889:
884:
874:
873:
872:
867:
862:
846:
844:
838:
837:
835:
834:
829:
824:
819:
814:
808:
806:
804:COX inhibitors
800:
799:
797:
796:
791:
786:
781:
775:
773:
762:
761:
759:
758:
757:
756:
751:
746:
731:
730:
729:
724:
719:
708:
706:
699:
694:
693:
691:
690:
685:
680:
675:
670:
665:
659:
657:
648:
642:
641:
629:anticoagulants
619:
617:
616:
609:
602:
594:
588:
587:
549:
527:
526:External links
524:
521:
520:
492:
463:
462:
460:
457:
398:
397:
380:
379:
376:
370:
369:
365:
364:
354:
346:
345:
343:
342:
334:DTXSID20872761
329:
327:
314:
313:
311:
310:
302:
300:
294:
293:
291:
290:
282:
280:
274:
273:
271:
270:
266:
264:
258:
257:
255:
254:
246:
244:
238:
237:
235:
234:
226:
224:
218:
217:
215:
214:
211:
203:
202:
201:
198:
197:
193:
192:
189:
183:
182:
179:
170:
169:
166:
160:
159:
152:
151:
149:
148:
137:
123:
121:
115:
114:
110:
109:
107:
106:
93:
91:
85:
84:
74:
72:administration
66:
65:
58:
48:
47:
44:
38:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
1617:
1606:
1603:
1601:
1598:
1597:
1595:
1584:
1579:
1577:
1572:
1570:
1565:
1564:
1558:
1556:
1552:
1548:
1544:
1540:
1535:
1532:
1528:
1523:
1508:
1506:
1503:
1502:
1500:
1497:
1494:
1491:
1489:
1486:
1485:
1481:
1475:
1472:
1470:
1467:
1465:
1462:
1461:
1459:
1457:
1456:Non-medicinal
1453:
1447:
1444:
1442:
1439:
1437:
1433:
1429:
1427:
1426:Streptokinase
1424:
1422:
1419:
1417:
1414:
1410:
1407:
1405:
1402:
1401:
1399:
1395:
1392:
1390:
1387:
1385:
1382:
1380:
1377:
1376:
1375:
1371:
1368:
1367:
1365:
1363:
1362:fibrinolytics
1358:
1354:
1344:
1341:
1339:
1336:
1332:
1329:
1328:
1327:
1324:
1322:
1319:
1317:
1314:
1312:
1309:
1307:
1304:
1303:
1301:
1297:
1291:
1288:
1286:
1283:
1281:
1278:
1276:
1273:
1271:
1268:
1266:
1262:
1259:
1255:
1252:
1250:
1247:
1245:
1242:
1241:
1240:
1236:
1233:
1232:
1230:
1228:
1224:
1214:
1211:
1209:
1206:
1204:
1201:
1199:
1196:
1194:
1191:
1189:
1186:
1185:
1183:
1180:
1176:
1168:
1165:
1163:
1160:
1158:
1155:
1154:
1153:
1150:
1146:
1143:
1141:
1138:
1137:
1136:
1133:
1129:
1126:
1124:
1121:
1119:
1116:
1114:
1111:
1109:
1106:
1104:
1101:
1099:
1096:
1094:
1091:
1090:
1089:
1086:
1085:
1083:
1080:
1074:
1069:
1065:
1062:
1057:
1053:
1047:
1043:
1041:
1038:
1036:
1033:
1031:
1027:
1024:
1022:
1019:
1017:
1016:Phenprocoumon
1014:
1012:
1009:
1007:
1004:
1002:
1001:Coumatetralyl
999:
997:
996:Acenocoumarol
993:
990:
989:
987:
984:
980:
976:
972:
967:
963:
960:
958:
954:
944:
941:
939:
936:
934:
931:
930:
928:
924:
918:
915:
913:
910:
908:
905:
904:
902:
900:
896:
888:
885:
883:
880:
879:
878:
875:
871:
868:
866:
863:
860:
856:
853:
852:
851:
848:
847:
845:
843:
839:
833:
830:
828:
825:
823:
820:
818:
815:
813:
810:
809:
807:
805:
801:
795:
792:
790:
787:
785:
782:
780:
777:
776:
774:
771:
767:
763:
755:
752:
750:
747:
745:
742:
741:
739:
735:
732:
728:
725:
723:
720:
718:
715:
714:
713:
710:
709:
707:
705:
702:
695:
689:
686:
684:
681:
679:
676:
674:
671:
669:
666:
664:
661:
660:
658:
656:
652:
649:
647:
643:
638:
634:
630:
626:
625:thrombolytics
622:
615:
610:
608:
603:
601:
596:
595:
592:
584:
580:
576:
572:
568:
564:
561:(3): 136–43.
560:
556:
550:
538:
534:
530:
529:
525:
515:
510:
506:
502:
496:
493:
481:
474:
468:
465:
458:
456:
454:
449:
447:
443:
439:
435:
431:
427:
422:
420:
416:
412:
408:
405:(trade names
404:
394:
387:
381:
377:
375:
371:
366:
362:
358:
355:
353:
351:ECHA InfoCard
347:
339:
335:
331:
330:
328:
319:
315:
308:
304:
303:
301:
299:
295:
288:
284:
283:
281:
279:
275:
268:
267:
265:
263:
259:
252:
248:
247:
245:
243:
239:
232:
228:
227:
225:
223:
219:
210:
206:
199:
194:
190:
188:
184:
180:
178:
171:
168:89% (SC dose)
167:
165:
161:
157:
153:
147:
138:
135:
125:
124:
122:
120:
116:
111:
103:
98:
95:
94:
92:
90:
86:
82:
81:haemodialysis
78:
75:
73:
67:
63:
59:
57:
53:
49:
45:
43:
39:
36:Clinical data
34:
30:
25:
1555:expanding it
1536:
1521:
1446:Fibrinolysin
1416:Anistreplase
1394:Desmoteplase
1389:Tenecteplase
1290:Ximelagatran
1140:Fondaparinux
1112:
1079:antithrombin
1035:Diphenadione
912:Dipyridamole
855:Dipyridamole
794:Treprostinil
789:Prostacyclin
668:Eptifibatide
558:
555:Pharmacology
554:
541:. Retrieved
536:
514:10665/345533
504:
495:
483:. Retrieved
479:
467:
450:
438:hemodialysis
423:
410:
406:
402:
401:
390:
384:
174:Elimination
119:Legal status
113:Legal status
79:(except for
1495:from market
1316:Defibrotide
1244:Bivalirudin
1213:Rivaroxaban
1152:Heparinoids
1145:Idraparinux
1046:Tioclomarol
1040:Phenindione
1030:Clorindione
933:Cloricromen
727:Ticlopidine
717:Clopidogrel
357:100.029.698
196:Identifiers
42:Trade names
1594:Categories
1421:Monteplase
1338:Ramatroban
1321:Nafamostat
1306:Abelacimab
1285:Melagatran
1270:Dabigatran
1265:Argatroban
1208:Otamixaban
1193:Betrixaban
1181:("xabans")
1167:Sulodexide
1157:Danaparoid
1128:Tinzaparin
1118:Parnaparin
1113:Nadroparin
1108:Enoxaparin
1103:Dalteparin
1098:Certoparin
1058:inhibitors
1006:Dicoumarol
907:Cilostazol
887:Terutroban
865:Picotamide
754:Ticagrelor
738:nucleoside
734:Nucleotide
704:inhibitors
683:Sibrafiban
459:References
407:Fraxiparin
403:Nadroparin
374:Molar mass
287:1K5KDI46KZ
262:ChemSpider
222:CAS Number
205:IUPAC name
1505:Phase III
1493:Withdrawn
1409:Urokinase
1404:Saruplase
1384:Reteplase
1379:Alteplase
1326:Protein C
1280:Inogatran
1275:Efegatran
1261:Univalent
1254:Lepirudin
1249:Desirudin
1198:Darexaban
1123:Reviparin
1093:Bemiparin
1056:Factor Xa
992:Coumarins
969:(inhibit
943:Vorapaxar
917:Triflusal
882:Terbogrel
870:Terbogrel
859:+ aspirin
832:Triflusal
827:Indobufen
817:Aloxiprin
779:Beraprost
749:Elinogrel
744:Cangrelor
722:Prasugrel
688:Tirofiban
678:Roxifiban
673:Orbofiban
663:Abciximab
231:9005-49-6
187:Excretion
176:half-life
70:Routes of
56:Drugs.com
1600:Heparins
1235:Bivalent
1203:Edoxaban
1188:Apixaban
1021:Warfarin
938:Ditazole
784:Iloprost
740:analogs
583:95878036
575:17057417
503:(2021).
393:(verify)
242:DrugBank
89:ATC code
1474:Oxalate
1464:Citrate
1441:Brinase
1239:Hirudin
1068:Heparin
1044:Other:
543:2 April
485:2 April
411:Fraxodi
251:DB08813
144::
105:)
99: (
97:B01AB06
1488:WHO-EM
1436:Ancrod
1430:Other
1077:(bind
1070:group/
581:
573:
307:D07510
146:℞-only
132:
1549:is a
1543:blood
1537:This
1374:r-tPA
1299:Other
926:Other
579:S2CID
476:(PDF)
1551:stub
1545:and
1539:drug
1469:EDTA
1400:UPA
1343:REG1
770:PGI2
631:and
571:PMID
545:2019
487:2019
428:and
298:KEGG
278:UNII
269:none
158:data
52:AHFS
975:VII
637:B01
635:) (
563:doi
509:hdl
323:EPA
102:WHO
1596::
1501::
1434::
1372::
1263::
1237::
1028::
994::
981:,
979:IX
977:,
973:,
971:II
700:12
627:,
577:.
569:.
559:78
557:.
535:.
478:.
455:.
448:.
421:.
409:,
141:CA
134:S4
128:AU
1582:e
1575:t
1568:v
1557:.
1359:/
1081:)
1075:/
985:)
983:X
861:)
857:(
772:)
768:(
736:/
639:)
623:(
613:e
606:t
599:v
585:.
565::
547:.
511::
489:.
325:)
321:(
130::
83:)
54:/
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
